Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Biocryst Pharmaceuticals | 14 | 0 | 2 | 0 | €8.96 | €17.26 | 92.613% |
| Bruker Corp. | 14 | 1 | 0 | 0 | €49.40 | €51.79 | 4.847% |
| Radnet Inc. | 13 | 0 | 2 | 0 | €66.12 | €71.92 | 8.776% |
| Exact Sciences | 13 | 0 | 0 | 0 | €90.74 | - | - |
| Personalis Inc | 13 | 0 | 3 | 0 | €12.13 | €14.53 | 19.802% |
| Pfizer Inc. | 15 | 2 | 2 | 0 | €23.05 | €29.70 | 28.839% |
| EyePoint Pharmaceuticals Inc. | 13 | 0 | 4 | 0 | €11.70 | €34.88 | 198.154% |
| Icon plc | 15 | 2 | 2 | 0 | €143.55 | €165.33 | 15.170% |
| LivaNova plc | 13 | 0 | 1 | 0 | €66.00 | €69.15 | 4.772% |
| Becton, Dickinson & Co. | 12 | 0 | 4 | 0 | €157.15 | €178.96 | 13.880% |
| Icu Medical Inc. | 12 | 0 | 3 | 0 | €157.00 | €159.50 | 1.595% |
| Ensign Group Inc. | 11 | 0 | 1 | 0 | €159.50 | €174.60 | 9.465% |
| Bayer AG | 11 | 0 | 0 | 0 | €49.19 | €50.00 | 1.647% |
| Innoviva Inc. | 11 | 0 | 1 | 0 | €17.70 | €35.91 | 102.893% |
| Lightpath Techs A | 11 | 0 | 1 | 0 | €11.40 | €14.03 | 23.113% |
| Omnicell Inc. | 11 | 0 | 3 | 0 | €31.80 | €44.97 | 41.421% |
| TG Therapeutics Inc. | 11 | 1 | 3 | 0 | €42.60 | €51.29 | 20.394% |
| Henry Schein Inc. | 13 | 3 | 3 | 0 | €77.50 | €78.18 | 0.879% |
| Addus Homecare Corp. | 13 | 3 | 1 | 0 | €101.00 | €117.90 | 16.732% |
| Vanda Pharmaceuticals | 10 | 0 | 1 | 0 | €4.26 | €17.17 | 303.194% |
| Novartis AG ADR | 11 | 1 | 2 | 0 | €134.00 | €150.99 | 12.677% |
| Brookdale Sr Lvg | 9 | 0 | 0 | 0 | €11.70 | €14.72 | 25.853% |
| US Physical Therapy Inc. | 9 | 0 | 2 | 0 | €70.00 | €87.61 | 25.160% |
| Teladoc Health Inc | 9 | 0 | 2 | 0 | €5.90 | €8.46 | 43.504% |
| Enanta Pharmaceuticals Inc. | 9 | 0 | 0 | 0 | €11.70 | €17.17 | 46.744% |